Preveceutical Medical Inc PRVCF

Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

CSE:PREV - Post by User

Preveceutical Medical Inc > @nirlops...

<< Previous

Bullboard Posts

Next >>

Comment by FXtheknobon Jun 13, 2020 12:17pm

212 Views

Post# 31146733

RE:RE:@nirlops...

FXtheknob wrote: Check out this post as it has some info. Voulume and price has increase substantially in the past month.

doubledowndon wrote:
Could @nirlops be referring to this? Hmmmmm?

https://www.contractpharma.com/contents/view_breaking-news/2020-06-02/pfizer-unveils-500m-biotech-fund/

Didn't Mak Jawadekar PreveCeutical's President and Chief Science Officer work for Pfizer at one time? They know who he is and how brilliant his work is.